Where Oncology Pharmacists, Residents, & Technicians access Chemotherapy Drug Information, Products, & Programs
OncologyPharmacist.NET is dedicated to providing timely information, consulting services, and links for Clinical Hem/Onc/BMT Pharmacists, Residents, and Technicians, in a single location, to be used on a daily basis. Improving Patient Care through the exchange of information is our goal. Our News and Clinical Tools sections will come from practice sites throughout the world. Our Job Boards will focus on relevant positions exclusively. Our Patient Assistant Programs area will link to sites that provide drugs that are used strictly in Hematology and Oncology. New Drugs will highlight Chemotherapy and Supportive Care drugs with new indications within the last 365 days. Our hope is to integrate CMS coding and announcements in the future as well as provide an area for Hem/Onc/BMT Residents, Technicians, and Practitioners to exchange ideas. Please bookmark our site, sign up to be listed on our Advisory Board Clinicians or Speakers List, send us suggestions or guidelines to improve the site, and consider advertising in this exciting domain. OP
NewsfeedCancer / Oncology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
'Over 184,000 global deaths each year' caused by sugary drinks
Researchers estimate that consumption of sugar-sweetened drinks may lead to more than 184,000 deaths worldwide annually, with most of these deaths caused by diabetes.
Grapefruit, orange juice linked to increased risk of melanoma
Consuming large amounts of grapefruit and orange juice may increase the risk of melanoma - the deadliest form of skin cancer - according to new research led by Brown University.
Data shows disconnect between healthcare professionals and patient perception...
Norgine B.V. has presented new data highlighting a perceptual gap between healthcare professionals and patients in terms of the incidence and impact on patients' daily life of chemotherapy and...
Long-term survival rates satisfactory for bladder cancer patients treated wit...
In the largest multi-institutional study to date, patients diagnosed with bladder cancer and treated with robot-assisted surgery experienced similar results to those who underwent a traditional...
National study finds life-threatening barriers in access to breakthrough drugs
Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C, according to Lynn E. Taylor, M.D.
Newsfeed display by CaRP
|Headquarters: Warwick, RI • ©2009 OncologyPharmacist.net|